These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2559442)

  • 41. Enzyme-linked immunosorbent assay for IgG antibodies to Epstein-Barr virus-associated early antigens and viral capsid antigen.
    Dölken G; Weitzmann U; Boldt C; Bitzer M; Brugger W; Löhr GW
    J Immunol Methods; 1984 Mar; 67(2):225-33. PubMed ID: 6323578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enzyme-linked immunosorbent assay for the detection of Epstein-Barr virus-induced antigens and antibodies.
    Sternås L; Luka J; Kallin B; Rosén A; Henle W; Henle G; Klein G
    J Immunol Methods; 1983 Oct; 63(2):171-85. PubMed ID: 6311908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
    Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
    Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies.
    Mueller-Lantzsch N; Georg-Fries B; Herbst H; zur Hausen H; Braun DG
    Int J Cancer; 1981 Sep; 28(3):321-7. PubMed ID: 6172392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.
    Pearson GR; Luka J; Petti L; Sample J; Birkenbach M; Braun D; Kieff E
    Virology; 1987 Sep; 160(1):151-61. PubMed ID: 2820125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential inducibility of Epstein-Barr virus in cloned, non-producer Raji cells.
    Bister K; Yamamoto N; zur Hausen H
    Int J Cancer; 1979 Jun; 23(6):818-25. PubMed ID: 89100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in Epstein-Barr virus (EBV) receptors expression on various human lymphoid targets and their significance to EBV-cell interaction.
    Stocco R; Sauvageau G; Menezes J
    Virus Res; 1988 Oct; 11(3):209-25. PubMed ID: 2848382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
    Maunders MJ; Petti L; Rowe M
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus and Herpesvirus saimiri: sensitivity to interferons and interferon inducers.
    Lvovsky E; Levine PH; Fuccillo D; Ablashi DV; Bengali ZH; Armstrong GR; Levy HB
    J Natl Cancer Inst; 1981 Jun; 66(6):1013-9. PubMed ID: 6165852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Appearance of Epstein-Barr virus nuclear antigen in human cordblood lymphocytes.
    Wright J; Falk L; Deinhardt F
    IARC Sci Publ (1971); 1975; (11 Pt 1):409-14. PubMed ID: 190146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide.
    Mueller-Lantzsch N; Yamamoto N
    J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals.
    Zhu XX; Zeng Y; Wolf H
    Int J Cancer; 1986 May; 37(5):689-91. PubMed ID: 3009331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Three Epstein-Barr virus (EBV)-determined nuclear antigens induced by the BamHI E region of EBV DNA.
    Shimizu N; Yamaki M; Sakuma S; Ono Y; Takada K
    Int J Cancer; 1988 May; 41(5):744-51. PubMed ID: 2835324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
    Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D
    Intervirology; 1975; 5(6):319-34. PubMed ID: 181343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Replication of Epstein-Barr virus: ultrastructural and immunofluorescent studies of P3HR1-superinfected Raji cells.
    Seigneurin JM; Vuillaume M; Lenoir G; De-Thé G
    J Virol; 1977 Dec; 24(3):836-45. PubMed ID: 201779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids.
    Klein G; Clements G; Zeuthen J; Westman A
    Cancer Lett; 1977 Jul; 3(1-2):91-8. PubMed ID: 196751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
    Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoclonal antibodies against Epstein-Barr virus transformed B lymphocytes from a CLL patient.
    Guha AK; Ghose T; Luner SJ; Nolido-Cruz H; Uniyal S; Rajaraman R; Fernandez LA; Lee SS; Lee CL
    Hybridoma; 1990 Apr; 9(2):119-32. PubMed ID: 2161403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.